Cambridge Investment Research Advisors »

Moleculin Biotech shares owned by Cambridge Investment Research Advisors

Quarter-by-quarter ownership of Moleculin Biotech (MBRX) shares owned by Cambridge Investment Research Advisors from 13F filings

Historical chart of Cambridge Investment Research Advisors investment in Moleculin Biotech

Tip: Access up to 7 years of quarterly data

All positions including Moleculin Biotech held by Cambridge Investment Research Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Moleculin Biotech by Cambridge Investment Research Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $7.0k 13k 0.55
2025-06-30 $4.0k 13k 0.31
2025-03-31 $12k 13k 0.94

More positions owned by Cambridge Investment Research Advisors

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Apple Inc Com (AAPL)
NVIDIA Corporation (NVDA)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Vanguard Index Fds Total Stk Mkt (VTI)
Ishares Tr Core S&p500 Etf (IVV)
Microsoft Corp Com (MSFT)
Amazon Com Inc Com (AMZN)
Vanguard Star Fds Vg Tl Intl Stk F (VXUS)
SPDR S&p 500 Etf Tr Tr Unit (SPY)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Capital Group Dividend Value Shs Creation Uni (CGDV)
Meta Platforms Inc Cl A (META)
Vanguard Index Fds Growth Etf (VUG)
Spdr Series Trust Portfolio S&P500 (SPLG)

View all positions for Cambridge Investment Research Advisors

Top funds holding Moleculin Biotech

Vanguard Group
Geode Capital Management
Hrt Financial
LPL Financial
Ieq Capital
Wealth Dimensions Group
Rockefeller Capital Management
Cambridge Investment Research Advisors
Goldman Sachs Group
BlackRock
Branch Banking & Trust Company
Ethos Financial Group
Moors & Cabot
Tower Research Capital
UBS Group

View all funds holding Moleculin Biotech